Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors.

CONCLUSION: Piperazine derivatives were found to be successful new scaffold as potential DPP-IV inhibitors. PMID: 32940185 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32940185?dopt=Abstract

Source: Medicinal Chemistry - September 15, 2020 Category: Chemistry Authors: Khalaf RA, Jarad HA, Al-Qirim T, Sabbah D Tags: Med Chem Source Type: research